@article{ae83f1ffcbf040468bc49681f1982d7a,
title = "ESTRO-ACROP guideline on surface guided radiation therapy",
abstract = "Surface guidance systems enable patient positioning and motion monitoring without using ionising radiation. Surface Guided Radiation Therapy (SGRT) has therefore been widely adopted in radiation therapy in recent years, but guidelines on workflows and specific quality assurance (QA) are lacking. This ESTROACROP guideline aims to give recommendations concerning SGRT roles and responsibilities and highlights common challenges and potential errors. Comprehensive guidelines for procurement, acceptance, commissioning, and QA of SGRT systems installed on computed tomography (CT) simulators, C-arm linacs, closed-bore linacs, and particle therapy treatment systems are presented that will help move to a consensus among SGRT users and facilitate a safe and efficient implementation and clinical application of SGRT. (c) 2022 The Author(s). Published by Elsevier B.V. Radiotherapy and Oncology xxx (2022) xxx-xxx This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).",
keywords = "SGRT, Surface guided radiation therapy, ESTRO, ACROP, Guideline, QUALITY-ASSURANCE, RADIOTHERAPY, SYSTEM",
author = "P. Freislederer and V. Batista and M. Ollers and M. Buschmann and E. Steiner and M. Kugele and F. Fracchiolla and S. Corradini and \{de Smet\}, M. and F. Moura and S. Perryck and F. Dionisi and D. Nguyen and C. Bert and J. Lehmann",
note = "Funding Information: PF has received speaker honoraria from C-Rad AB and Brainlab AG, is currently employed by Brainlab AG; However, at the time of the conception and the implementation of the guideline, PF was not employed by Brainlab AG. PF declares that his employment had no influence on the guideline design, the collection and the analysis of data, on the writing of the manuscript or the decision to submit the guideline for publication. MS and VB have received speaker honoraria from VisionRT Ltd. SC has received research grants and speaker honoraria/travel support from Elekta AB, ViewRay technologies, Inc. and Brainlab AG. MO has received speaker honoraria from C-RAD AB. All other authors have no conflict of interest. Funding Information: The authors thank all members of the ESTRO SGRT working group for their useful input and contributions during the initial phase of the guideline process. The authors would like to thank the reviewers Gail Anastasi, Hania al-Hallaq, Jeremy Hoisak, Marco Schwarz and Amanda Webster for their comprehensive review of this guideline and their useful and constructive comments. PF has received speaker honoraria from C-Rad AB and Brainlab AG, is currently employed by Brainlab AG; However, at the time of the conception and the implementation of the guideline, PF was not employed by Brainlab AG. PF declares that his employment had no influence on the guideline design, the collection and the analysis of data, on the writing of the manuscript or the decision to submit the guideline for publication. MS and VB have received speaker honoraria from VisionRT Ltd. SC has received research grants and speaker honoraria/travel support from Elekta AB, ViewRay technologies, Inc. and Brainlab AG. MO has received speaker honoraria from C-RAD AB. All other authors have no conflict of interest. ESTRO cannot endorse all statements or opinions made on the guidelines. Regardless of the vast professional knowledge and scientific expertise in the field of radiation oncology that ESTRO possesses, the Society cannot inspect all information to determine the truthfulness, accuracy, reliability, completeness or relevancy thereof. Under no circumstances will ESTRO be held liable for any decision taken or acted upon as a result of reliance on the content of the guidelines. The component information of the guidelines is not intended or implied to be a substitute for professional medical advice or medical care. The advice of a medical professional should always be sought prior to commencing any form of medical treatment. To this end, all component information contained within the guidelines is done so for solely educational and scientific purposes. ESTRO and all of its staff, agents and members disclaim any and all warranties and representations with regards to the information contained on the guidelines. This includes any implied warranties and conditions that may be derived from the aforementioned guidelines. Publisher Copyright: {\textcopyright} 2022 The Author(s)",
year = "2022",
month = aug,
day = "1",
doi = "10.1016/j.radonc.2022.05.026",
language = "English",
volume = "173",
pages = "188--196",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
}